Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Aug;35(8):2055–2060. doi: 10.1128/jcm.35.8.2055-2060.1997

Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers.

C Segonds 1, E Bingen 1, G Couetdic 1, S Mathy 1, N Brahimi 1, N Marty 1, P Plesiat 1, Y Michel-Briand 1, G Chabanon 1
PMCID: PMC229902  PMID: 9230381

Abstract

Burkholderia cepacia has been involved in outbreaks of pulmonary infection among patients with cystic fibrosis (CF), and the spread of a highly transmissible clone has been reported throughout the United Kingdom and Canada. These data prompted a DNA-based typing study of the strains recovered in French CF centers. Ninety-five isolates recovered from 71 patients attending 13 CF centers in 9 regions of France were characterized by randomly amplified polymorphic DNA (RAPD) analysis and pulsed-field gel electrophoresis (PFGE). Twenty-one genotypes were identified among the 95 isolates, and the results of RAPD and PFGE were concordant for 89 isolates (94%). Cross-colonization was demonstrated in 7 of the 13 CF centers. The investigation of serial isolates showed that most chronically colonized patients harbored a single B. cepacia strain. A geographically clustered distribution of B. cepacia genotypes was observed, except for one genotype, which was detected in four regions but was proven to be different from the genotype of the British-Canadian highly transmissible strain. The present study confirms the ability of B. cepacia to spread among CF communities in France and the importance of epidemiological surveys in the institution of prevention policies.

Full Text

The Full Text of this article is available as a PDF (575.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. J., Kuhns J. S., Vasil M. L., Gerding D. N., Janoff E. N. DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak. J Clin Microbiol. 1991 Mar;29(3):648–649. doi: 10.1128/jcm.29.3.648-649.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barsomian G., Lessie T. G. Replicon fusions promoted by insertion sequences on Pseudomonas cepacia plasmid pTGL6. Mol Gen Genet. 1986 Aug;204(2):273–280. doi: 10.1007/BF00425509. [DOI] [PubMed] [Google Scholar]
  3. Bingen E. H., Weber M., Derelle J., Brahimi N., Lambert-Zechovsky N. Y., Vidailhet M., Navarro J., Elion J. Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients. J Clin Microbiol. 1993 Oct;31(10):2589–2593. doi: 10.1128/jcm.31.10.2589-2593.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Butler S. L., Doherty C. J., Hughes J. E., Nelson J. W., Govan J. R. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J Clin Microbiol. 1995 Apr;33(4):1001–1004. doi: 10.1128/jcm.33.4.1001-1004.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cheng H. P., Lessie T. G. Multiple replicons constituting the genome of Pseudomonas cepacia 17616. J Bacteriol. 1994 Jul;176(13):4034–4042. doi: 10.1128/jb.176.13.4034-4042.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Christenson J. C., Welch D. F., Mukwaya G., Muszynski M. J., Weaver R. E., Brenner D. J. Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol. 1989 Feb;27(2):270–273. doi: 10.1128/jcm.27.2.270-273.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cimolai Nevio, Trombley Colleen. Enterobacterial intergenic consensus sequence polymerase chain reaction as a typing method for Burkholderia (Pseudomonas) cepacia. Clin Microbiol Infect. 1996 Aug;2(1):59–62. doi: 10.1111/j.1469-0691.1996.tb00201.x. [DOI] [PubMed] [Google Scholar]
  8. Dasen S. E., LiPuma J. J., Kostman J. R., Stull T. L. Characterization of PCR-ribotyping for Burkholderia (Pseudomonas) cepacia. J Clin Microbiol. 1994 Oct;32(10):2422–2424. doi: 10.1128/jcm.32.10.2422-2424.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fisher M. C., LiPuma J. J., Dasen S. E., Caputo G. C., Mortensen J. E., McGowan K. L., Stull T. L. Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment. J Pediatr. 1993 Nov;123(5):745–747. doi: 10.1016/s0022-3476(05)80851-0. [DOI] [PubMed] [Google Scholar]
  10. Godard C., Plesiat P., Michel-Briand Y. Persistence of Pseudomonas aeruginosa strains in seven cystic fibrosis patients followed over 20 months. Eur J Med. 1993 Feb;2(2):117–120. [PubMed] [Google Scholar]
  11. Goldstein R., Sun L., Jiang R. Z., Sajjan U., Forstner J. F., Campanelli C. Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J Bacteriol. 1995 Feb;177(4):1039–1052. doi: 10.1128/jb.177.4.1039-1052.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Govan J. R., Brown P. H., Maddison J., Doherty C. J., Nelson J. W., Dodd M., Greening A. P., Webb A. K. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet. 1993 Jul 3;342(8862):15–19. doi: 10.1016/0140-6736(93)91881-l. [DOI] [PubMed] [Google Scholar]
  13. Govan J. R., Hughes J. E., Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol. 1996 Dec;45(6):395–407. doi: 10.1099/00222615-45-6-395. [DOI] [PubMed] [Google Scholar]
  14. Isles A., Maclusky I., Corey M., Gold R., Prober C., Fleming P., Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984 Feb;104(2):206–210. doi: 10.1016/s0022-3476(84)80993-2. [DOI] [PubMed] [Google Scholar]
  15. Johnson W. M., Tyler S. D., Rozee K. R. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol. 1994 Apr;32(4):924–930. doi: 10.1128/jcm.32.4.924-930.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kiska D. L., Kerr A., Jones M. C., Caracciolo J. A., Eskridge B., Jordan M., Miller S., Hughes D., King N., Gilligan P. H. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol. 1996 Apr;34(4):886–891. doi: 10.1128/jcm.34.4.886-891.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kostman J. R., Edlind T. D., LiPuma J. J., Stull T. L. Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping. J Clin Microbiol. 1992 Aug;30(8):2084–2087. doi: 10.1128/jcm.30.8.2084-2087.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Larsen G. Y., Stull T. L., Burns J. L. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J Clin Microbiol. 1993 Apr;31(4):788–792. doi: 10.1128/jcm.31.4.788-792.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lewin L. O., Byard P. J., Davis P. B. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol. 1990;43(2):125–131. doi: 10.1016/0895-4356(90)90175-o. [DOI] [PubMed] [Google Scholar]
  20. LiPuma J. J., Fisher M. C., Dasen S. E., Mortensen J. E., Stull T. L. Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia. J Infect Dis. 1991 Jul;164(1):133–136. doi: 10.1093/infdis/164.1.133. [DOI] [PubMed] [Google Scholar]
  21. LiPuma J. J., Mortensen J. E., Dasen S. E., Edlind T. D., Schidlow D. V., Burns J. L., Stull T. L. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr. 1988 Nov;113(5):859–862. doi: 10.1016/s0022-3476(88)80018-0. [DOI] [PubMed] [Google Scholar]
  22. Liu P. Y., Shi Z. Y., Lau Y. J., Hu B. S., Shyr J. M., Tsai W. S., Lin Y. H., Tseng C. Y. Comparison of different PCR approaches for characterization of Burkholderia (Pseudomonas) cepacia isolates. J Clin Microbiol. 1995 Dec;33(12):3304–3307. doi: 10.1128/jcm.33.12.3304-3307.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mahenthiralingam E., Campbell M. E., Henry D. A., Speert D. P. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol. 1996 Dec;34(12):2914–2920. doi: 10.1128/jcm.34.12.2914-2920.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ouchi K., Abe M., Karita M., Oguri T., Igari J., Nakazawa T. Analysis of strains of Burkholderia (Pseudomonas) cepacia isolated in a nosocomial outbreak by biochemical and genomic typing. J Clin Microbiol. 1995 Sep;33(9):2353–2357. doi: 10.1128/jcm.33.9.2353-2357.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Pitt T. L., Kaufmann M. E., Patel P. S., Benge L. C., Gaskin S., Livermore D. M. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol. 1996 Mar;44(3):203–210. doi: 10.1099/00222615-44-3-203. [DOI] [PubMed] [Google Scholar]
  26. Rabkin C. S., Jarvis W. R., Anderson R. L., Govan J., Klinger J., LiPuma J., Martone W. J., Monteil H., Richard C., Shigeta S. Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis. 1989 Jul-Aug;11(4):600–607. doi: 10.1093/clinids/11.4.600. [DOI] [PubMed] [Google Scholar]
  27. Rodley P. D., Römling U., Tümmler B. A physical genome map of the Burkholderia cepacia type strain. Mol Microbiol. 1995 Jul;17(1):57–67. doi: 10.1111/j.1365-2958.1995.mmi_17010057.x. [DOI] [PubMed] [Google Scholar]
  28. Sajjan U. S., Sun L., Goldstein R., Forstner J. F. Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol. 1995 Feb;177(4):1030–1038. doi: 10.1128/jb.177.4.1030-1038.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Segonds C., Chabanon G., Couetdic G., Michel-Briand Y., Bingen E. Epidemiology of pulmonary colonization with Burkholderia cepacia in cystic fibrosis patients. The French Observatoire Burkholderia cepacia Study Group. Eur J Clin Microbiol Infect Dis. 1996 Oct;15(10):841–842. doi: 10.1007/BF01701534. [DOI] [PubMed] [Google Scholar]
  30. Simpson I. N., Finlay J., Winstanley D. J., Dewhurst N., Nelson J. W., Butler S. L., Govan J. R. Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis. J Antimicrob Chemother. 1994 Sep;34(3):353–361. doi: 10.1093/jac/34.3.353. [DOI] [PubMed] [Google Scholar]
  31. Smith D. L., Gumery L. B., Smith E. G., Stableforth D. E., Kaufmann M. E., Pitt T. L. Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol. 1993 Nov;31(11):3017–3022. doi: 10.1128/jcm.31.11.3017-3022.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Smyth A., Heaf D., Corkill J., Hart T., Sisson P., Freeman R. Transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet. 1993 Aug 14;342(8868):434–435. [PubMed] [Google Scholar]
  33. Steinbach S., Sun L., Jiang R. Z., Flume P., Gilligan P., Egan T. M., Goldstein R. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med. 1994 Oct 13;331(15):981–987. doi: 10.1056/NEJM199410133311504. [DOI] [PubMed] [Google Scholar]
  34. Sun L., Jiang R. Z., Steinbach S., Holmes A., Campanelli C., Forstner J., Sajjan U., Tan Y., Riley M., Goldstein R. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med. 1995 Jul;1(7):661–666. doi: 10.1038/nm0795-661. [DOI] [PubMed] [Google Scholar]
  35. Tablan O. C., Martone W. J., Jarvis W. R. The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis. Eur J Epidemiol. 1987 Dec;3(4):336–342. doi: 10.1007/BF00145642. [DOI] [PubMed] [Google Scholar]
  36. Tenover F. C., Arbeit R. D., Goering R. V., Mickelsen P. A., Murray B. E., Persing D. H., Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995 Sep;33(9):2233–2239. doi: 10.1128/jcm.33.9.2233-2239.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Tyler S. D., Rozee K. R., Johnson W. M. Identification of IS1356, a new insertion sequence, and its association with IS402 in epidemic strains of Burkholderia cepacia infecting cystic fibrosis patients. J Clin Microbiol. 1996 Jul;34(7):1610–1616. doi: 10.1128/jcm.34.7.1610-1616.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wood M. S., Lory C., Lessie T. G. Activation of the lac genes of Tn951 by insertion sequences from Pseudomonas cepacia. J Bacteriol. 1990 Apr;172(4):1719–1724. doi: 10.1128/jb.172.4.1719-1724.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. van Belkum A., Kluytmans J., van Leeuwen W., Bax R., Quint W., Peters E., Fluit A., Vandenbroucke-Grauls C., van den Brule A., Koeleman H. Multicenter evaluation of arbitrarily primed PCR for typing of Staphylococcus aureus strains. J Clin Microbiol. 1995 Jun;33(6):1537–1547. doi: 10.1128/jcm.33.6.1537-1547.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES